All posts by imreal

BirdEye Partners with athenahealth’s Marketplace Program to Help Healthcare Practices Get New Reviews and Improve Patient Experience


BirdEye Partners with athenahealth’s Marketplace Program

BirdEye Partners with athenahealth’s Marketplace Program

BirdEye delivers a valuable service for healthcare practices. The BirdEye platform allows practices to collect and leverage customer reviews in order to acquire new patients and improve the patient experience.

BirdEye, the leading customer experience platform, today announced a partnership with athenahealth, Inc., through athenahealth’s Marketplace program. As part of the athenahealth® Marketplace, this newly integrated application is now available to athenahealth’s growing network of 160,000 healthcare providers to get more online reviews, monitor patient feedback, and improve the patient experience.

With BirdEye, businesses capture, analyze, and promote customer feedback in order to improve operations and drive revenue growth. BirdEye’s suite of products includes review monitoring, review generation, review marketing, customer referrals, customer surveys, social listening, social publishing, social engagement, customer support ticketing, listings management, webchat, business insights and competitive benchmarking.

“BirdEye delivers a valuable service for healthcare practices,” said David Tulkin, Director of Business Development. “The BirdEye platform allows practices to collect and leverage customer reviews in order to acquire new patients and improve the patient experience.”

athenahealth is a network-enabled, results-oriented services company that offers medical record, revenue cycle, patient engagement, care coordination, and population health services for hospital and ambulatory clients. The company’s vision is to build a thriving ecosystem that delivers accessible, high-quality and sustainable healthcare for all. As a Marketplace partner, BirdEye joins a network of like-minded healthcare professionals who are looking to disrupt established approaches in healthcare that simply aren’t working, aren’t good enough, or aren’t advancing the industry and help providers thrive in the face of industry change.

To learn more about BirdEye’s new integrated application, please visit BirdEye’s product listing page on the Marketplace.

About BirdEye

BirdEye drives business growth by getting new reviews and improving customer experience. More than 50,000 businesses use BirdEye’s all-in-one platform to effectively manage their reviews, be found online, become the obvious choice, and increase revenue. Founded in 2012, BirdEye is headquartered in Palo Alto, CA and led by alumni from Google, Amazon, and Yahoo. In 2019, BirdEye was ranked the #1 leader in Online Reputation Management by G2 Crowd. BirdEye is backed by Salesforce founder Marc Benioff, Yahoo co-founder Jerry Yang, Trinity Ventures and World Innovation Lab. To learn more, please visit: https://birdeye.com

About athenahealth Marketplace

The athenahealth Marketplace, the largest EHR app store, is where athenahealth customers find innovative healthcare IT solutions that extend athenahealth services and allow customers to create highly tailored user experiences. Our customers use Marketplace partner solutions to boost practice efficiency, increase patient satisfaction, and engage patients in their own care. The Marketplace has more than 200 solutions across 60 categories that are seamlessly integrated with athenaNet, athenahealth’s network-enabled platform through which the company offers medical records, revenue cycle, patient engagement, care coordination, and population health services.

Share article on social media or email:

Operation Homefront Appoints Greg Ham to Its Board of Directors


“Greg will be an absolutely incredible addition to a very talented and engaged board of directors,” said Brig. Gen. (ret.) John I. Pray Jr., president and CEO of Operation Homefront.

Operation Homefront, which has been serving America’s military families® since 2002, announced today that Greg Ham has joined the nonprofit’s national Board of Directors. Ham is currently a partner at The MWS Group, a multi-rights entertainment content company in partnership with Michael W. Smith, which represents the careers of Michael W. Smith, CeCe Winans, Olympian Scott Hamilton, and author Frank Peretti. Ham also manages Robert Deaton, an Emmy award winning director/producer. Deaton is Executive Producer of the CMA Awards for ABC & the Billboard Music Awards on NBC via Dick Clark Productions.

“Greg will be an absolutely incredible addition to a very talented and engaged board of directors,” said Brig. Gen. (ret.) John I. Pray Jr., president and CEO of Operation Homefront. “A widely respected leader in the entertainment industry, Greg’s expertise and insights will be of great value in helping us accomplish our important mission to give military families the opportunity to thrive, not simply struggle to get by, in the communities – our communities – they have worked so hard to protect.”

Ham has spent the last 30 years in the music and entertainment business working with artists like dc Talk, Audio Adrenaline, and Rebecca St. James. He started his career at ForeFront Records in 1989 where he held multiple positions leading up to president in 1998. Under his leadership, ForeFront had two of its most successful years with the launch of Stacie Orrico’s career and her self-titled album, which sold over 2.5 million units, and the launch of TobyMac’s solo career, as well as, several other artists on the roster.

In 2004, Ham began his role as Executive Vice President of Business Development for EMI CMG (Christian Music Group) worldwide. He served on the EMI, (its labels included Capitol Records and Virgin Records), Global Marketing team working with such greats as Coldplay, Janet Jackson, the Beatles 1 album, and many more artists over the next four years. He also developed many valuable relationships with EMI’s global marketing teams and many external business partners.

“The entire board is thrilled Greg Ham has accepted our invitation to join our vital efforts to support our military families,” said MG (r) Lee Baxter, chairman of Operation Homefront’s Board of Directors. “Greg is nationally known for his exceptional work in and contributions to the entertainment industry and with his help, we know we will be able to do even more to serve those who have done so much to protect the freedoms we, as Americans, enjoy daily.”

“I am thankful for the opportunity to be part of an amazing organization that serves America’s military families,” said Ham.

Ham left EMI CMG in 2007, and then took some time off with his family to go on a 65-day adventure around the world. During the trip, he and his family volunteered at an orphanage in China, and in Nairobi, Kenya, served by doing AIDS work with Compassion International.

About Operation Homefront:

Founded in 2002, Operation Homefront is a national nonprofit organization whose mission is to build strong, stable, and secure military families so that they can thrive – not simply struggle to get by – in the communities they have worked so hard to protect. Recognized for superior performance by leading independent charity oversight groups, 92 percent of Operation Homefront expenditures go directly to programs that support tens of thousands of military families each year. Operation Homefront provides critical financial assistance, transitional and permanent housing and family support services to prevent short-term needs from turning into chronic, long-term struggles. Thanks to the generosity of our donors and the support from thousands of volunteers, Operation Homefront proudly serves America’s military families. For more information, visit OperationHomefront.org.

Share article on social media or email:

DXL Group Continues to Build Legacy at St. Jude Children’s Research Hospital® During Annual St. Jude Thanks and Giving® Campaign


Give to help him live

St. Jude patient Maverick and his mom

“We are honored to have this partnership with St. Jude. There’s nothing more important than saving a child’s life and that’s why we all — associates and customers alike — continue to give.” Harvey Kanter, President and Chief Executive Officer at DXL

Destination XL Group, Inc. (Nasdaq: DXLG), the leading retailer of men’s big + tall apparel, announced today it is continuing their partnership with St. Jude Children’s Research Hospital® for the St. Jude Thanks and Giving® campaign, an unprecedented union of celebrities, media, and more than 60 of the nation’s leading brands and companies that ask consumers to donate while they shop during the holiday season to support the lifesaving mission of St. Jude.

This is the fifteenth year DXL has participated in the campaign, which began as a holiday season fundraising effort and has grown into a longstanding annual tradition. Since joining the campaign, DXL has raised more than $12 million thanks to the tremendous support of its customers and associates. These funds are critical given that no family ever receives a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live.

Since 2017, DXL has raised $3 million in donations for the hospital, representing a quarter of their donation commitment of $12 million by year-end 2026. At this rate, it is likely they will surpass their donation goal. In recognition of the donation commitment, the name “DXL Men’s Apparel” has been attached to the Light Microscopy Center at the Memphis-based hospital.

“We are honored to have this partnership with St. Jude. There’s nothing more important than saving a child’s life and that’s why we all — associates and customers alike — continue to give.” said Harvey Kanter, President and Chief Executive Officer at DXL. “Supporting the lifesaving mission of St. Jude Children’s Research Hospital is part of our culture here at DXL and one that we’re immensely proud of as a company.”

The campaign launched on Monday, October 28 and will run through Sunday, January 5. DXL’s customers can support the campaign by donating at their local store. In addition, DXL will have a variety of fundraisers at the corporate office.

“I give thanks this holiday season for the loyal support of DXL Group as we kick off the St. Jude Thanks and Giving campaign,” said Marlo Thomas, National Outreach Director for St. Jude Children’s Research Hospital. “The caring and unwavering commitment of DXL Group, their dedicated employees and generous customers to the children of St. Jude is instrumental in helping raise the necessary funds to ensure that families never pay St. Jude for anything – not for treatment, travel, housing or food – because we believe all a family should worry about is helping their child live.”

Created by siblings Marlo, Terre and Tony Thomas – children of St. Jude founder Danny Thomas – the St. Jude Thanks and Giving campaign asks people to “Give thanks for the healthy kids in your life, and give to those who are not” in order to help the hospital carry out its mission: Finding cures. Saving children. ®

To find your local DXL Big + Tall store visit DXL.com. To learn more about the St. Jude Thanks and Giving campaign or to make a donation, visit http://www.stjude.org or call 1-800-4STJUDE.

About St. Jude Children’s Research Hospital

St. Jude Children’s Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. Its purpose is clear: Finding cures. Saving children.® It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to more than 80 percent since the hospital opened more than 50 years ago. St. Jude won’t stop until no child dies from cancer. St. Jude freely shares the discoveries it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live. Join the St. Jude mission by visiting stjude.org, sharing stories and videos from St. Jude Inspire, liking St. Jude on Facebook, following St. Jude on Twitter and Instagram and subscribing to its YouTube channel.

About Destination XL Group

Destination XL Group, Inc. is the largest retailer of men’s clothing in sizes XL and up, with operations throughout the United States as well as in Ontario, Canada. In addition to DXL Men’s Apparel retail and outlet stores, subsidiaries of Destination XL Group, Inc. also operate Rochester Clothing stores, Casual Male XL retail and outlet stores, and the e-commerce site,DXL.com. DXL.com offers a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for the XL guy. The Company is headquartered in Canton, Massachusetts, and its common stock is listed on the NASDAQ Global Market under the symbol “DXLG.” Sizes start at 38” waist and XL including tall sizes, plus shoe sizes 10-16, in widths to 4E. Follow @destinationXL on Facebook, Instagram and Twitter.

Share article on social media or email:



The Family God Created,” unexpected disasters can’t compare to the suffering a family will face from men with evil intent


News Image

“Esther’s Story: The Family God Created”: shows how the Lord sometimes puts obstacles in one’s intended path that will lead them to the one He has chosen, but this can only happen if one is open to listen to Him and choose to go His way. While fiction, the events depicted in this story can and do happen to people today. As it did in 1972 to P.K. Thomas, after she attended Bible College and saw her priorities and life goals change. Since graduating from the University of Arkansas in 1990, God has been directing her life to serve Him through the talents and skills He has given her.

In her first book, “Esther’s Story: Journey from the Cross”, P.K. Thomas brought the first century birth of Christianity alive by blending Biblical truth, and human history as seen through the eyes of one young girl on her journey of faith to find God’s purpose for her life.

“As Esther’s story continues in her second book, ‘Esther’s Story: The Family God Created,’ we will follow this now young woman, along with her husband, Anthony, and their adopted son, Nymes, on their intended mission to bring the Word of God to Anthony’s mother’s family in Macedonia. However, a journey that was expected to be only a few months takes an unexpected turn when a massive earthquake changes their plans and direction, putting them on a long detour filled with many hardships and difficulties. Despite these many obstacles and hardships that God has put in front of them, they push on. Unsure as to when or if they will reach their intended destination and if they do, what will they find?

“Facing these many obstacles requires a bending of their wills and a testing of their faith in order to make the right Godly choices to meet both the physical and spiritual needs of others. But what at first appears to be just a series of unrelated encounters turns out to be much, much more as they discover God’s hand at work and see His greater purpose through all the difficult choices that they will make.”    

Published by Christian Faith Publishing, P.K. Thomas’ new book reads like a movie as one moves from scene to scene and sees the development of not just Esther’s family, but the family of God. In this beautiful narrative, the reader will learn that the greatest dangers and the greatest joys are found not in the obstacles one faces, but in the decisions one makes in dealing with them. Just as the characters in this book, everyone must face their challenges with faith and trust in the Lord.

View a synopsis of “Esther’s Story: The Family God Created” on YouTube.

Consumers can purchase “Esther’s Story: The Family God Created” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Esther’s Story: The Family God Created,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Anchor Stablecoin is Now Live and Available for Trading on IDEX Exchange


Anchor’s token listing on IDEX, one of the world’s leading decentralized exchanges, marks an important milestone in our promise to provide a scalable and viable alternative to fiat-pegged stablecoins to crypto traders, businesses, governments, and individuals around the world.

Anchor (ANCT), a two-token, algorithmic stablecoin pegged to the sustainable and predictable growth trend of the global economy, is now listed and available for trading on IDEX, the world’s leading decentralized cryptocurrency exchange. IDEX provides retail and institutional traders with a secure, trustless, and real-time trading experience backed by transparent blockchain settlements.

Following Anchor’s token launch on Liquid in August, IDEX is the second exchange to list the stablecoin offering ANCT for purchasing, selling, and trading to crypto traders, investors, and stablecoin enthusiasts. ANCT offers token users a hedge against daily market volatility, long-term price stability with steady appreciation over time, ease of fiat currency on-ramp and off-ramp, and liquidity.

IDEX CEO Alex Wearn said, “Next-generation stablecoins like Anchor (ANCT) hold a promising future. We’re excited to play a part in unlocking more diverse financial services and options for our traders.”

Anchor Founder and CEO Daniel Popa stated, “Anchor’s token listing on IDEX, one of the world’s leading decentralized exchanges, marks an important milestone in our promise to provide a scalable and viable alternative to fiat-pegged stablecoins to crypto traders, businesses, governments, and individuals around the world. As the first to market a new category of digital global currencies, Anchor is uniquely independent from any fiat currency’s value and is pegged 1-to-1 with the Monetary Measurement Unit (MMU), a non-flationary financial index, which reflects the sustainable growth of the global economy.”

A two-token, algorithmic stablecoin, Anchor is pegged to global economic growth via the Monetary Measurement Unit (MMU). The MMU is a non-flationary financial index created by an algorithm that tracks a series of macroeconomic indicators to provide the most accurate, available measure of real value that exists in the world today.

Stablecoins backed by fiat are susceptible to the same market fluctuations, depreciation, and loss of purchasing power as their traditional counterparts to which they are pegged. The global economy, on the other hand, has a sustainable and predictable growth trend with global GDP steadily increasing over time. Providing an alternative to fiat-pegged stablecoins, Anchor will remain stable regardless of any fiat currency’s strength, market fluctuations, or economic recessions.

Anchor’s next-generation tokenomics incorporates an elastic supply rule that adjusts the quantity of coin supply proportionately to changes in Anchor’s market value with a two-token, burn-mint model that adheres to naturally occurring Contraction and Expansion Phases. Anchor Tokens (ANCT) serve as the main currency/payment tokens, while Dock Tokens (DOCT) serve as the utility tokens that ensure ANCT remains pegged to the MMU regardless of external market fluctuations.

Beyond trading, Anchor’s stablecoin could be leveraged to significantly reduce fees and transaction times when sending remittances or making international payments via wire transfer or credit card. The unbanked can join the Anchor Economy simply by downloading the Anchor Wallet to a mobile phone, which enables funds to be stored, sent, and received without value lost due to transaction fees. Furthermore, Anchor’s financial index, the MMU, has the potential to become a new financial standard and an ideal value peg for countries issuing their own sovereign cryptocurrencies, such as the Marshall Islands along with 18 other countries creating or researching the issuance of a decentralized digital currency.

In addition, Anchor is planning to enter its first round of fundraising and will be offering traditional equity in exchange for financing from institutional investors, VCs, and private equity firms. Chief Communications Officer, Olya Moskalenko will be available to meet with interested parties during Invest: NYC at the New York Marriott Marquis between November 11th – 13th.

Users can purchase and trade Anchor (ANCT) on IDEX now by signing up or logging into their IDEX accounts and following this link: https://idex.market/eth/anct

Please note, trading ANCT on IDEX from the United States is currently unavailable.

—-

For media inquiries, please contact:

Olya Moskalenko

Chief Communications Officer

olya.moskalenko(at)theanchor.io

Kili Wall

Melrose PR Account Executive

Kili(at)melrosepr.com

+1 (310) 260-7901

About Anchor

Anchor is a stablecoin cryptocurrency pegged to a non-flationary, algorithmic index that reflects the long-term growth of the global economy. The Monetary Measurement Unit (MMU) algorithm is based on the GDP of more than 190 countries and further stabilized with FX indicators from a basket of eight currencies, and premium sovereign bond yields from 10 of the world’s strongest economies. Offering the stablecoin market an alternative to fiat-pegged stablecoins, Anchor’s tokenomics ecosystem is designed to be intrinsically stable with its MMU and safety-net of six stabilizing mechanisms, including a two-token, burn-mint model to ensure stability and equilibrium regardless of market growth or recession. CEO Daniel Popa, a serial telecom and software entrepreneur with over 20 years experience running successful multinational companies, has led a team of PhD economists in developing Anchor’s proprietary MMU. Anchor’s network of partners includes Ambisafe, blockchain infrastructure provider that previously worked with Tether; as well as KYC Spider, a digital KYC compliance tool for financial intermediaries and the fintech industry.

About IDEX

IDEX is the #1 DEX on Ethereum, providing retail and institutional customers with a secure, trustless, and real-time trading experience backed by transparent blockchain settlement. Through a hybrid design that manages trade matching and balance updates off-chain, IDEX eliminates mining delays and enables continuous trading, multiple simultaneous orders, and zero-fee cancellations.

For more information about IDEX, please visit https://idex.market/eth/idex.

Share article on social media or email:

Noblis to Offer Insights on the Potential of Large-scale Autonomous Systems at NVTC Autonomous Technology Summit on Nov. 7


Noblis award winning, Autonomy at Scale concept is helping realize the vision of trusted autonomous operations allowing connected vehicles to communicate, self-organize and safely interact.

” … The recent launch of our Pieces of Eight (Po8) -Trusted Autonomy program demonstrates how forward-thinking research and technical solutions are helping government and commercial customers solve complex challenges,” said Amr ElSawy, president and chief executive officer, Noblis.

Researchers from Noblis, a leading provider of science, technology and strategy services to the federal government, will discuss how earned trust and blockchain technology can enable autonomous systems to transform how we travel and deliver goods at the Northern Virginia Technology Council (NVTC) Autonomous Technology Summit on Nov. 7, at the INOVA Center for Personalized Health in Fairfax.

The summit, in partnership with the Virginia Unmanned Systems Center at CIT, will feature experts from commercial, defense, regulatory and academic sectors discussing the opportunities, challenges and impacts of autonomous technology, and showcase Virginia’s leadership in autonomous systems. More information on the summit is available at: https://autonomous.nvtc.org/

“We are delighted to be part of NVTC’s summit,” said Amr ElSawy, president and chief executive officer, Noblis. “One of the many research efforts Noblis has undertaken in the past few years is to study the effects of autonomy on a larger scale across air, sea, land, space, and cyber domains. The recent launch of our Pieces of Eight (Po8) -Trusted Autonomy program demonstrates how forward-thinking research and technical solutions are helping government and commercial customers solve complex challenges.”

The Noblis Po8 trusted autonomous operations concept has received significant recognition since its public release. It will be recognized with a 2019 Government – Industry Innovator award from 1105 Public Sector Media Group on Nov. 7; and it earned the Highest Potential Impact Award and the Most Creative Award at the MOBI (mobility open blockchain initiative) Grand Challenge in Munich, Germany in February 2019.

At the summit, Noblis’ Karl Wunderlich, director of surface transportations systems, will offer a keynote on the transformative benefits of autonomous systems, heterogenous, unfamiliar and connected machines and their need to self-organize and develop relationships that are similar to human trust – but also fundamentally different. Noblis researcher Drew Dudash will participate in a panel and share insights on how blockchain technology allows unfamiliar, heterogenous machines to form ad hoc, many-to-many relationships with each other and the surrounding IoT ecosystem, and how it can improve cybersecurity.

ABOUT NOBLIS

Noblis is a dynamic science, technology, and strategy organization dedicated to creating forward-thinking technical and advisory solutions in the public interest. We bring the best of scientific thought, management, and engineering expertise together in an environment of independence and objectivity to deliver enduring impact on federal missions. Noblis works with a wide range of government clients in the defense, intelligence and federal civil sectors. Together with our wholly owned subsidiary, Noblis ESI, we tackle the nation’s toughest problems and support our clients’ most critical missions.

Share article on social media or email:

2019 CFLD Beijing Marathon – A Gift of Celebration


The cool autumn morning of November 3rd, at 7:30, in Tiananmen Square, one of the largest public squares in the world, echoed the starting signal of the top marathon event in China.

This year, the organizers received over 160,000 applications for the event, 30,000 runners from around the world eventually took part in the race.

At the end of this much anticipated running event, Mathew Kipkoech Kisorio from Kenya was the first broke through the finishing line, took this year’s champion title in men’s category with the time of 2:07:06; Solomon Kirwa Yego and Emmanuel Rutto Naibei following through with times of 2:09:45 and 2:10:15, taking the 2nd and 3rd place respectively.

In women’s category, Sutume Asefa Kebede from Ethiopia won the first place in 2:23:31; Li Zhi Xuan came in 2nd in 2:29:06, and Mulu Seboka Seyfu finished in 3rd in 2:29:09.

To ensure yet another memorable racing experience for all who participated, and in celebration of the nation’s 70th Birthday, organizers provided runners with plenty of supplies to power them throughout the race, including over 400,000 bottles of water, plus energy drinks, energy bars, bananas, cakes, milk and snacks along the racing routes. There were medical stations every 2.5km after the initial 5km mark, and first aid volunteers every 100 meters; 20 ambulances and more than 300 medical personnel were on standby.

http://bit.ly/2Nf5vuH

Text and Photo Credits: CFLD Beijing Marathon

Share article on social media or email:

New Podcast Sponsored by Asymmetrex Increases Awareness to the Need for Stem Cell Dose in Stem Cell Treatments


Asymmetrex Sponsors Podcast on “Counting Stem Cells for a New Era of Medicine”

Dose is essential for stem cell medicine as well.

In October, Massachusetts stem cell biotechnology company Asymmetrex launched a new podcast to provide information to patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem cell medical practice, stem cell treatments are given without knowing the dose of the treating stem cells. This problem affects all patients receiving stem cell treatments, including patients receiving approved treatments in routine clinical practice, patients volunteering for experimental treatments in FDA-authorized clinical trials, and patients obtaining unapproved treatments in private stem cell clinics.

The costs and dangers of unknown stem cell dose in treatments are significant. Stem cell clinical trials cannot be interpreted without knowing the treatment dose, leading to huge wastes of both federal and private clinical research dollars. In the case of manufactured stem cells, many treatments may contain very few or no stem cells at all. It is impossible for doctors to improve treatments without knowing the stem cell dose. Stem cell donors for approved treatments like blood stem cell transplantation are scarce. Knowing the stem cell dose would allow doctors to know when a treatment sample has enough stem cells to treat more than one patient; or when it does not have enough to treat even a single patient. In the second case, not knowing the stem cell dose can result in the death of children treated for leukemia when unknowingly they receive an umbilical cord blood transplant with too few blood stem cells to save them.

Earlier this year, the FDA recognized the pressing need for stem cell dose in stem cell medicine. The agency’s Standards Coordinating Body for Regenerative Medicine (SCB) listed stem cell dose determination as a priority for needed standards for stem cell medicine. Dose is a fundamental principle for the discovery, development, and administration of quality medicines. Asymmetrex Director James L. Sherley, M.D., Ph.D., who is featured in the new podcast, says that, “Dose is essential for stem cell medicine as well. The new podcast has the goal of informing the end users of stem cell treatments: the patients, their doctors, their families, and their advocates, including the FDA. When the people most impacted by these treatments understand that knowing the dose of stem cells is just as important as knowing the dose of their other medicines, they will be empowered to demand this essential certification of the integrity of their stem cell treatments.”

The first episode of the podcast, “Counting Stem Cells For A New Era Of Medicine,” aired online on October 17. The third episode of the biweekly, 6-episode series is scheduled for airing November 12. Each episode features an interview of Asymmetrex Director Sherley by podcast producer Jordan Rich. Mr. Rich guides Dr. Sherley through a discussion of questions that reveal the current challenges that Asymmetrex is addressing to achieve full adoption of stem cell dose as a routine practice in stem cell medicine. The series also highlights other significant applications for stem cell counting in drug development and environmental health science. In conjunction with this educational effort, the company is also sponsoring a study on its website to evaluate the current state of public, academic, and industry knowledge of coming changes in stem cell medicine related to the adoption of stem cell dose.

About Asymmetrex

Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex’s founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The company’s patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Asymmetrex markets the first technology for determination of the dose and quality of tissue stem cell preparations (the “AlphaSTEM Test™”) for use in stem cell transplantation therapies and pre-clinical drug evaluations.

Share article on social media or email:

Solvang Insurance Agent, Rick Torres, Releases The Top Reasons To Bundle Insurance Coverage


News Image

When your insurance policies are with the same company, you have a very important benefit and customer commitment that comes with centralized risk assessment.

Combining home or renters insurance with auto insurance makes good sense for the budget but there are other very tangible benefits to bundle insurance policies. Rick Torres, Solvang insurance agent recently released the top reasons for people to consider combining insurance coverage.

It’s not uncommon for people to have auto insurance with one company and homeowners or renters with another. When starting out, a young, single person gets car insurance either through their parents’ insurance or on the recommendation of a friend or a television commercial. Later, when out on their own and they start accumulating furniture and electronics, they may get renter’s insurance to protect their possessions or may be required to carry a minimum policy by a landlord. As life moves along and they start families, buy homes, buy new cars, they continue to shop for the best deals in insurance without investigating the benefits of combining policies.

Aside from the potential savings, someone gets by combining insurance policies, there are other benefits such as:


  • Convenience: The convenience of keeping track of only one due date instead of two or more is a plus in anyone’s busy schedule. Also, consider the fact that there is one number to call with questions or to make a claim.
  • Personal attention: Combining insurance policies with one company means you have an insurance agent who gives your insurance needs personal attention. Regular policy reviews are scheduled to keep your coverage at the best level for your current circumstances. There is only one person to call when life changes your insurance needs. There aren’t many life changes that don’t require a thorough insurance review. Getting married or divorced, having children, a new job or a promotion, graduating college, even buying a home can mean changes to insurance on that paid for 10-year old car you’ve been driving since it was new.
  • Better risk assessment: Changes in life circumstances can mean it’s time for a new risk assessment. Unfortunately, all the good things that come our way in life can leave us vulnerable in the event of accidents. This includes traffic accidents, fender-benders, a visitor tripping and falling on your front porch, your dog playing too rough with the neighbor’s kid and scratching an arm or leg. Even when someone accidentally injured in your vehicle or on your property has the best intentions, medical complications that take the matter beyond anyone’s control can happen.

When your insurance policies are with the same company, you have a very important benefit and customer commitment that comes with centralized risk assessment. An invaluable asset is having one agent who knows your policies and when to make the best recommendations for you.

The Rick Torres Insurance Agency in Solvang, CA is committed to providing policyholders the highest quality of service by making sure individuals and families are insured for the best protection with the least impact on the budget as possible. Call today to find about combining insurance coverage, getting a current risk assessment, and to discover the many other benefits of working with the Rick Torres Insurance Agency.

Rick Torres Insurance Agency, Inc.

540 Alisal Road, Suite 4

Solvang, CA 93463

(805) 688-5418

This press release is by Paso Robles advertising company Access Publishing, 806 9th Street, #2D, Paso Robles, CA 93446, (805) 226-9890.

Share article on social media or email:

Catalent’s Chair & Chief Executive Officer, John Chiminski, Receives First Ever ‘Lifetime Achievement’ Award at CPhI Worldwide


Catalent’s Chair & Chief Executive Officer, John Chiminski

Catalent’s Chair & Chief Executive Officer, John Chiminski

I am extremely proud to lead a company of highly talented people who are totally committed to bringing better, innovative treatments to market, in the shortest possible timeframe, ultimately improving patient outcomes.

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that its Chair and Chief Executive Officer, John Chiminski, has received the inaugural CPhI Pharma Awards ‘Lifetime Achievement Award’ at the world’s largest pharmaceutical exhibition, CPhI Worldwide, currently taking place at Messe Frankfurt, Germany.

The judges considered Mr. Chiminski to be ‘an exceptional individual with a consistent history of service, above and beyond the call of duty’ throughout his career. The award was announced at a Gala Dinner on Tuesday, November 5th. Established in 2004, the CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry. The awards celebrate thinkers and creators breaking new ground and strongly advocate companies committed to driving the industry forward.

On receiving the award, Mr. Chiminski commented, “I would like to sincerely thank the judges and my industry peers for this recognition and feel deeply honored.” He added, “I am extremely proud to lead a company of highly talented people who are totally committed to bringing better, innovative treatments to market, in the shortest possible timeframe, ultimately improving patient outcomes.”

Over a 10-year period, Mr. Chiminski has led Catalent’s transformation into the world’s leading drug delivery technology, development and supply organization, overseeing a successful IPO in 2014. Since then he has driven the company’s growth strategy, both organically and through acquisitions, to ensure maximum return on investment for shareholders.

Today, he heads an organization employing nearly 13,000 people, including approximately 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue.

Mr. Chiminski joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles.

He holds a Bachelors of Sciences from Michigan State University and a Master of Sciences from Purdue University, both in electrical engineering, as well as a master’s degree in management from the Kellogg School of Management at Northwestern University.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email: